Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $109.49M.
ENTERPRISE VALUE (EV)
$109.49M
Vivani Medical, Inc.
Market Cap
$108.66M
Enterprise Value (EV)
$109.49M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Vivani Medical, Inc. (VANI) | $108.66M | $109.49M |
| Outlook Therapeutics, Inc. (OTLK)vs › | $108.46M | $115.65M |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $108.33M | $35.15M |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $108.18M | $109.03M |
| Apyx Medical Corporation (APYX)vs › | $109.91M | $121.92M |
| Immunic, Inc. (IMUX)vs › | $107.09M | N/A |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $106.91M | $87.81M |
| Definitive Healthcare Corp. (DH)vs › | $105.19M | $101.38M |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $105.15M | $102.92M |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $112.53M | $97.40M |
Market Cap
$108.66M
Total Debt
$17.06M
Cash
$16.23M
Enterprise Value
$109.49M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
